| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | extracellular matrix structural constituent | RELN COMP DSPP LAMA5 SPOCK2 SLIT2 FBLN1 THBS3 THBS4 FBN1 HMCN2 HMCN1 MUC2 | 1.17e-08 | 188 | 175 | 13 | GO:0005201 |
| GeneOntologyMolecularFunction | calcium ion binding | FAT4 COMP DSPP CRTAC1 SPOCK2 CHORDC1 PPEF2 ADGRE2 CBLB SLIT2 EDEM3 FBLN1 THBS3 THBS4 FBN1 DST HMCN2 HMCN1 NRXN1 NCAN SLIT1 LRP4 PLCB3 CALN1 | 4.17e-08 | 749 | 175 | 24 | GO:0005509 |
| GeneOntologyBiologicalProcess | regulation of synapse organization | RELN KIF1A MYO5B KALRN USP9X PPP1R9A CRTAC1 ADGRE2 ADNP SLIT2 PTPN13 NRXN1 NCAN SLIT1 NGEF LRP4 ELAVL2 | 3.29e-08 | 387 | 174 | 17 | GO:0050807 |
| GeneOntologyBiologicalProcess | regulation of synapse structure or activity | RELN KIF1A MYO5B KALRN USP9X PPP1R9A CRTAC1 ADGRE2 ADNP SLIT2 PTPN13 NRXN1 NCAN SLIT1 NGEF LRP4 ELAVL2 | 4.42e-08 | 395 | 174 | 17 | GO:0050803 |
| GeneOntologyBiologicalProcess | cell junction organization | RELN CEACAM5 KIF1A MYO5B KALRN USP9X PPP1R9A LAMA5 CRTAC1 SPOCK2 ADGRE2 ADNP SHROOM2 SLIT2 GJA4 PTPN13 DST HMCN2 NRXN1 NCAN SLIT1 NGEF LRP4 ELAVL2 ILDR1 GJA10 TNR | 4.96e-08 | 974 | 174 | 27 | GO:0034330 |
| GeneOntologyBiologicalProcess | cell morphogenesis | RELN HECW1 KIF1A MYO5B KALRN USP9X PPP1R9A LAMA5 ADNP SHROOM2 WDR47 SLIT2 THBS4 DST LATS2 HMCN2 NRXN1 FEZ2 HECW2 ZNF335 SLIT1 NGEF LRP4 PDZD8 COBL ATF4 ARHGEF26 TNR PLXNA1 EPB41 | 7.18e-08 | 1194 | 174 | 30 | GO:0000902 |
| GeneOntologyBiologicalProcess | neuron projection morphogenesis | RELN HECW1 KIF1A MYO5B KALRN USP9X PPP1R9A LAMA5 ADNP WDR47 SLIT2 THBS4 DST HMCN2 NRXN1 FEZ2 HECW2 ZNF335 SLIT1 NGEF LRP4 COBL TNR PLXNA1 | 7.35e-08 | 802 | 174 | 24 | GO:0048812 |
| GeneOntologyBiologicalProcess | synapse organization | RELN KIF1A MYO5B KALRN USP9X PPP1R9A LAMA5 CRTAC1 SPOCK2 ADGRE2 ADNP SLIT2 PTPN13 HMCN2 NRXN1 NCAN SLIT1 NGEF LRP4 ELAVL2 GJA10 TNR | 8.02e-08 | 685 | 174 | 22 | GO:0050808 |
| GeneOntologyBiologicalProcess | plasma membrane bounded cell projection morphogenesis | RELN HECW1 KIF1A MYO5B KALRN USP9X PPP1R9A LAMA5 ADNP WDR47 SLIT2 THBS4 DST HMCN2 NRXN1 FEZ2 HECW2 ZNF335 SLIT1 NGEF LRP4 COBL TNR PLXNA1 | 1.08e-07 | 819 | 174 | 24 | GO:0120039 |
| GeneOntologyBiologicalProcess | cell projection morphogenesis | RELN HECW1 KIF1A MYO5B KALRN USP9X PPP1R9A LAMA5 ADNP WDR47 SLIT2 THBS4 DST HMCN2 NRXN1 FEZ2 HECW2 ZNF335 SLIT1 NGEF LRP4 COBL TNR PLXNA1 | 1.27e-07 | 826 | 174 | 24 | GO:0048858 |
| GeneOntologyBiologicalProcess | cell morphogenesis involved in neuron differentiation | RELN HECW1 KIF1A MYO5B KALRN USP9X PPP1R9A LAMA5 ADNP WDR47 SLIT2 DST HMCN2 NRXN1 FEZ2 HECW2 SLIT1 NGEF LRP4 COBL TNR PLXNA1 | 3.63e-07 | 748 | 174 | 22 | GO:0048667 |
| GeneOntologyBiologicalProcess | synapse assembly | RELN USP9X PPP1R9A CRTAC1 SPOCK2 ADGRE2 ADNP SLIT2 PTPN13 NRXN1 SLIT1 LRP4 ELAVL2 GJA10 | 3.75e-07 | 308 | 174 | 14 | GO:0007416 |
| GeneOntologyBiologicalProcess | regulation of synapse assembly | USP9X PPP1R9A CRTAC1 ADGRE2 ADNP SLIT2 PTPN13 NRXN1 SLIT1 LRP4 ELAVL2 | 1.21e-06 | 202 | 174 | 11 | GO:0051963 |
| GeneOntologyBiologicalProcess | positive regulation of mRNA splicing, via spliceosome | 1.79e-06 | 44 | 174 | 6 | GO:0048026 | |
| GeneOntologyBiologicalProcess | positive regulation of mRNA processing | 3.42e-06 | 49 | 174 | 6 | GO:0050685 | |
| GeneOntologyBiologicalProcess | activation of GTPase activity | 4.02e-06 | 109 | 174 | 8 | GO:0090630 | |
| GeneOntologyBiologicalProcess | axonogenesis | RELN MYO5B KALRN USP9X LAMA5 ADNP WDR47 SLIT2 DST HMCN2 NRXN1 FEZ2 SLIT1 LRP4 COBL TNR PLXNA1 | 6.41e-06 | 566 | 174 | 17 | GO:0007409 |
| GeneOntologyBiologicalProcess | cell junction assembly | RELN USP9X PPP1R9A CRTAC1 SPOCK2 ADGRE2 ADNP SLIT2 GJA4 PTPN13 DST NRXN1 SLIT1 LRP4 ELAVL2 ILDR1 GJA10 | 6.87e-06 | 569 | 174 | 17 | GO:0034329 |
| GeneOntologyBiologicalProcess | axon development | RELN MYO5B KALRN USP9X LAMA5 CRTAC1 ADNP WDR47 SLIT2 DST HMCN2 NRXN1 FEZ2 SLIT1 LRP4 COBL TNR PLXNA1 | 8.69e-06 | 642 | 174 | 18 | GO:0061564 |
| GeneOntologyBiologicalProcess | neuron projection development | FAT4 RELN HECW1 KIF1A MYO5B KALRN USP9X PPP1R9A LAMA5 CRTAC1 ADNP WDR47 SLIT2 THBS4 DST HMCN2 NRXN1 FEZ2 HECW2 ZNF335 SLIT1 NGEF LRP4 COBL PRMT1 TNR PLXNA1 | 1.03e-05 | 1285 | 174 | 27 | GO:0031175 |
| GeneOntologyBiologicalProcess | positive regulation of RNA splicing | 1.51e-05 | 63 | 174 | 6 | GO:0033120 | |
| GeneOntologyBiologicalProcess | regulation of postsynapse organization | 2.84e-05 | 185 | 174 | 9 | GO:0099175 | |
| GeneOntologyBiologicalProcess | neuron development | FAT4 RELN HECW1 KIF1A MYO5B KALRN USP9X PPP1R9A LAMA5 CRTAC1 ADNP WDR47 SLIT2 THBS4 DST HMCN2 NRXN1 FEZ2 HECW2 ZNF335 SLIT1 NGEF LRP4 COBL PRMT1 TNR CNGB1 PLXNA1 | 3.78e-05 | 1463 | 174 | 28 | GO:0048666 |
| GeneOntologyBiologicalProcess | dendrite morphogenesis | 4.82e-05 | 198 | 174 | 9 | GO:0048813 | |
| GeneOntologyBiologicalProcess | dendritic spine morphogenesis | 6.36e-05 | 81 | 174 | 6 | GO:0060997 | |
| GeneOntologyBiologicalProcess | regulation of neuron projection development | RELN HECW1 KIF1A MYO5B KALRN PPP1R9A ADNP SLIT2 NRXN1 HECW2 SLIT1 NGEF LRP4 COBL TNR PLXNA1 | 6.46e-05 | 612 | 174 | 16 | GO:0010975 |
| GeneOntologyBiologicalProcess | regulation of cell junction assembly | USP9X PPP1R9A CRTAC1 ADGRE2 ADNP SLIT2 PTPN13 NRXN1 SLIT1 LRP4 ELAVL2 | 6.59e-05 | 309 | 174 | 11 | GO:1901888 |
| GeneOntologyBiologicalProcess | postsynapse organization | RELN KIF1A MYO5B KALRN USP9X PPP1R9A LAMA5 NRXN1 NCAN NGEF LRP4 | 7.39e-05 | 313 | 174 | 11 | GO:0099173 |
| GeneOntologyBiologicalProcess | positive regulation of T-helper cell differentiation | 1.29e-04 | 31 | 174 | 4 | GO:0045624 | |
| GeneOntologyBiologicalProcess | regulation of GTPase activity | AGAP5 KALRN RALGAPA2 CBLB NGEF AGAP9 AGAP7P ARHGEF26 AGAP4 AGAP6 PLXNA1 | 1.35e-04 | 335 | 174 | 11 | GO:0043087 |
| GeneOntologyBiologicalProcess | neuron projection guidance | 1.64e-04 | 286 | 174 | 10 | GO:0097485 | |
| GeneOntologyBiologicalProcess | protein ubiquitination | ZSWIM8 RMND5A RNF168 HECW1 USP9X WWP1 RIPK2 KEAP1 CBLB UBOX5 UBR7 RNF43 MALT1 HECW2 SOCS5 N4BP1 BTRC MGRN1 | 1.79e-04 | 811 | 174 | 18 | GO:0016567 |
| GeneOntologyBiologicalProcess | regulation of dendritic spine morphogenesis | 2.06e-04 | 64 | 174 | 5 | GO:0061001 | |
| GeneOntologyBiologicalProcess | chemorepulsion involved in embryonic olfactory bulb interneuron precursor migration | 2.11e-04 | 3 | 174 | 2 | GO:0021834 | |
| GeneOntologyBiologicalProcess | positive regulation of GTPase activity | 2.35e-04 | 244 | 174 | 9 | GO:0043547 | |
| GeneOntologyBiologicalProcess | regulation of nervous system development | RELN MYO5B KALRN ADGRE2 ADNP SLIT2 PTPN13 NRXN1 ZNF335 NCAN SLIT1 LRP4 TNR PLXNA1 PCM1 | 2.78e-04 | 625 | 174 | 15 | GO:0051960 |
| GeneOntologyBiologicalProcess | protein modification by small protein conjugation or removal | ZSWIM8 RMND5A RNF168 HECW1 USP9X WWP1 RIPK2 KEAP1 CBLB MINDY2 UBOX5 UBR7 RNF43 MALT1 HECW2 SOCS5 N4BP1 USPL1 BTRC MGRN1 | 3.44e-04 | 1009 | 174 | 20 | GO:0070647 |
| GeneOntologyBiologicalProcess | telencephalon cell migration | 3.57e-04 | 72 | 174 | 5 | GO:0022029 | |
| GeneOntologyBiologicalProcess | regulation of cell development | RELN PDE3A CEACAM5 MYO5B KALRN RIPK2 ADNP ZBTB1 SLIT2 MALT1 FBN1 ZNF335 NCAN SOCS5 SLIT1 LRP4 PRMT1 TNR PLXNA1 IL23R PCM1 | 3.77e-04 | 1095 | 174 | 21 | GO:0060284 |
| GeneOntologyBiologicalProcess | dorsal/ventral axon guidance | 4.20e-04 | 4 | 174 | 2 | GO:0033563 | |
| GeneOntologyBiologicalProcess | forebrain cell migration | 4.32e-04 | 75 | 174 | 5 | GO:0021885 | |
| GeneOntologyBiologicalProcess | dendritic spine organization | 4.35e-04 | 115 | 174 | 6 | GO:0097061 | |
| GeneOntologyBiologicalProcess | positive regulation of CD4-positive, alpha-beta T cell differentiation | 5.57e-04 | 45 | 174 | 4 | GO:0043372 | |
| GeneOntologyBiologicalProcess | protein modification by small protein conjugation | ZSWIM8 RMND5A RNF168 HECW1 USP9X WWP1 RIPK2 KEAP1 CBLB UBOX5 UBR7 RNF43 MALT1 HECW2 SOCS5 N4BP1 BTRC MGRN1 | 5.66e-04 | 893 | 174 | 18 | GO:0032446 |
| GeneOntologyBiologicalProcess | dendrite development | 5.75e-04 | 335 | 174 | 10 | GO:0016358 | |
| GeneOntologyBiologicalProcess | embryonic olfactory bulb interneuron precursor migration | 6.96e-04 | 5 | 174 | 2 | GO:0021831 | |
| GeneOntologyBiologicalProcess | axon guidance | 7.26e-04 | 285 | 174 | 9 | GO:0007411 | |
| GeneOntologyBiologicalProcess | positive regulation of cell development | RELN PDE3A MYO5B KALRN RIPK2 ADNP ZBTB1 SLIT2 MALT1 ZNF335 NCAN SOCS5 PLXNA1 IL23R | 7.34e-04 | 614 | 174 | 14 | GO:0010720 |
| GeneOntologyBiologicalProcess | neuron projection organization | 7.36e-04 | 127 | 174 | 6 | GO:0106027 | |
| GeneOntologyBiologicalProcess | post-translational protein modification | ZSWIM8 RMND5A RNF168 HECW1 USP9X WWP1 RIPK2 KEAP1 CBLB MINDY2 UBOX5 UBR7 RNF43 MALT1 HECW2 SOCS5 N4BP1 USPL1 BTRC MGRN1 | 7.54e-04 | 1074 | 174 | 20 | GO:0043687 |
| GeneOntologyBiologicalProcess | positive regulation of protein binding | 7.67e-04 | 85 | 174 | 5 | GO:0032092 | |
| GeneOntologyCellularComponent | collagen-containing extracellular matrix | RELN COMP DSPP LAMA5 SPOCK2 SLIT2 FBLN1 THBS3 THBS4 FBN1 DST HMCN2 HMCN1 NCAN MUC2 TNR | 8.35e-06 | 530 | 172 | 16 | GO:0062023 |
| GeneOntologyCellularComponent | extracellular matrix | RELN COMP DSPP LAMA5 SPOCK2 SLIT2 FBLN1 THBS3 THBS4 FBN1 DST HMCN2 HMCN1 ADAMTS7 NCAN MUC2 TNR | 3.09e-05 | 656 | 172 | 17 | GO:0031012 |
| GeneOntologyCellularComponent | external encapsulating structure | RELN COMP DSPP LAMA5 SPOCK2 SLIT2 FBLN1 THBS3 THBS4 FBN1 DST HMCN2 HMCN1 ADAMTS7 NCAN MUC2 TNR | 3.21e-05 | 658 | 172 | 17 | GO:0030312 |
| GeneOntologyCellularComponent | basement membrane | 6.84e-05 | 122 | 172 | 7 | GO:0005604 | |
| GeneOntologyCellularComponent | synapse-associated extracellular matrix | 1.47e-04 | 13 | 172 | 3 | GO:0099535 | |
| GeneOntologyCellularComponent | extracellular matrix of synaptic cleft | 2.01e-04 | 3 | 172 | 2 | GO:0098965 | |
| GeneOntologyCellularComponent | axon | RELN KIF1A FSCN3 USP9X PPP1R9A CRTAC1 ADNP WDR47 SLIT2 DST HMCN2 NRXN1 FEZ2 NGEF COBL EEA1 CNGB1 UNC80 | 4.10e-04 | 891 | 172 | 18 | GO:0030424 |
| GeneOntologyCellularComponent | growth cone | 9.84e-04 | 245 | 172 | 8 | GO:0030426 | |
| GeneOntologyCellularComponent | cell cortex | MYO5B PPP1R9A PARD3B STOX1 SHROOM2 DST HMCN2 HMCN1 COBL EPB41 | 1.04e-03 | 371 | 172 | 10 | GO:0005938 |
| GeneOntologyCellularComponent | site of polarized growth | 1.21e-03 | 253 | 172 | 8 | GO:0030427 | |
| MousePheno | fused cornea and lens | 8.85e-08 | 24 | 136 | 6 | MP:0001307 | |
| MousePheno | abnormal ureteric bud morphology | 1.83e-05 | 57 | 136 | 6 | MP:0006032 | |
| MousePheno | absent pinna reflex | 2.51e-05 | 89 | 136 | 7 | MP:0006358 | |
| MousePheno | abnormal centrosome morphology | 3.68e-05 | 20 | 136 | 4 | MP:0030943 | |
| MousePheno | mesocardia | 3.68e-05 | 20 | 136 | 4 | MP:0000650 | |
| MousePheno | abnormal microtubule organizing center morphology | 5.47e-05 | 22 | 136 | 4 | MP:0030942 | |
| MousePheno | abnormal pinna reflex | 5.68e-05 | 101 | 136 | 7 | MP:0001485 | |
| MousePheno | abnormal lens development | 1.10e-04 | 78 | 136 | 6 | MP:0005545 | |
| Domain | EGF-like_dom | PCSK5 FAT4 RELN COMP LAMA5 CRTAC1 ADGRE2 SLIT2 FBLN1 THBS3 THBS4 FBN1 HMCN2 HMCN1 NRXN1 BTC NCAN SLIT1 LRP4 TNR | 1.16e-13 | 249 | 169 | 20 | IPR000742 |
| Domain | EGF_Ca-bd_CS | FAT4 COMP CRTAC1 ADGRE2 SLIT2 FBLN1 THBS3 THBS4 FBN1 HMCN2 HMCN1 NCAN SLIT1 LRP4 | 2.09e-13 | 97 | 169 | 14 | IPR018097 |
| Domain | EGF_CA | FAT4 COMP CRTAC1 ADGRE2 SLIT2 FBLN1 THBS3 THBS4 FBN1 HMCN2 HMCN1 NCAN SLIT1 LRP4 | 2.79e-13 | 99 | 169 | 14 | PS01187 |
| Domain | EGF_1 | FAT4 RELN COMP LAMA5 CRTAC1 ADGRE2 SLIT2 FBLN1 THBS3 THBS4 FBN1 HMCN2 HMCN1 NRXN1 BTC NCAN SLIT1 LRP4 TNR | 1.88e-12 | 255 | 169 | 19 | PS00022 |
| Domain | EGF-like_CS | FAT4 RELN COMP LAMA5 CRTAC1 ADGRE2 SLIT2 FBLN1 THBS3 THBS4 FBN1 HMCN2 HMCN1 NRXN1 BTC NCAN SLIT1 LRP4 TNR | 2.84e-12 | 261 | 169 | 19 | IPR013032 |
| Domain | EGF_2 | FAT4 RELN COMP LAMA5 CRTAC1 ADGRE2 SLIT2 FBLN1 THBS3 THBS4 FBN1 HMCN2 HMCN1 NRXN1 BTC NCAN SLIT1 LRP4 TNR | 3.72e-12 | 265 | 169 | 19 | PS01186 |
| Domain | EGF | PCSK5 FAT4 RELN COMP LAMA5 ADGRE2 SLIT2 FBLN1 THBS3 THBS4 FBN1 HMCN1 NRXN1 BTC NCAN SLIT1 LRP4 TNR | 4.68e-12 | 235 | 169 | 18 | SM00181 |
| Domain | EGF_3 | FAT4 RELN COMP CRTAC1 ADGRE2 SLIT2 FBLN1 THBS3 THBS4 FBN1 HMCN2 HMCN1 NRXN1 BTC NCAN SLIT1 LRP4 TNR | 4.68e-12 | 235 | 169 | 18 | PS50026 |
| Domain | EGF_CA | FAT4 COMP CRTAC1 ADGRE2 SLIT2 FBLN1 THBS3 THBS4 FBN1 HMCN2 HMCN1 NCAN SLIT1 LRP4 | 5.26e-12 | 122 | 169 | 14 | SM00179 |
| Domain | EGF-like_Ca-bd_dom | FAT4 COMP CRTAC1 ADGRE2 SLIT2 FBLN1 THBS3 THBS4 FBN1 HMCN2 HMCN1 NCAN SLIT1 LRP4 | 6.58e-12 | 124 | 169 | 14 | IPR001881 |
| Domain | EGF_CA | FAT4 COMP CRTAC1 ADGRE2 FBLN1 THBS3 THBS4 FBN1 HMCN2 HMCN1 LRP4 | 3.27e-10 | 86 | 169 | 11 | PF07645 |
| Domain | Growth_fac_rcpt_ | PCSK5 FAT4 COMP LAMA5 ADGRE2 FBLN1 THBS3 THBS4 FBN1 HMCN2 HMCN1 SLIT1 LRP4 | 1.74e-09 | 156 | 169 | 13 | IPR009030 |
| Domain | RBM1CTR | 3.13e-09 | 8 | 169 | 5 | PF08081 | |
| Domain | RBM1CTR | 3.13e-09 | 8 | 169 | 5 | IPR012604 | |
| Domain | EGF-type_Asp/Asn_hydroxyl_site | FAT4 ADGRE2 SLIT2 FBLN1 FBN1 HMCN2 HMCN1 NRXN1 NCAN SLIT1 LRP4 | 3.18e-09 | 106 | 169 | 11 | IPR000152 |
| Domain | ASX_HYDROXYL | 2.42e-08 | 100 | 169 | 10 | PS00010 | |
| Domain | - | 1.98e-07 | 95 | 169 | 9 | 2.60.120.200 | |
| Domain | COMP | 7.28e-07 | 3 | 169 | 3 | PF11598 | |
| Domain | Thbs/COMP_coiled-coil | 7.28e-07 | 3 | 169 | 3 | IPR024665 | |
| Domain | Laminin_G | 8.94e-07 | 58 | 169 | 7 | IPR001791 | |
| Domain | ArfGap | 5.69e-06 | 29 | 169 | 5 | SM00105 | |
| Domain | ARFGAP | 5.69e-06 | 29 | 169 | 5 | PS50115 | |
| Domain | ArfGap | 5.69e-06 | 29 | 169 | 5 | PF01412 | |
| Domain | ArfGAP | 5.69e-06 | 29 | 169 | 5 | IPR001164 | |
| Domain | TSP_3 | 7.18e-06 | 5 | 169 | 3 | PF02412 | |
| Domain | TSP3 | 7.18e-06 | 5 | 169 | 3 | PS51234 | |
| Domain | TSP_CTER | 7.18e-06 | 5 | 169 | 3 | PS51236 | |
| Domain | Thrombospondin_3_rpt | 7.18e-06 | 5 | 169 | 3 | IPR017897 | |
| Domain | TSP_type-3_rpt | 7.18e-06 | 5 | 169 | 3 | IPR028974 | |
| Domain | - | 7.18e-06 | 5 | 169 | 3 | 4.10.1080.10 | |
| Domain | Thrombospondin_C | 7.18e-06 | 5 | 169 | 3 | IPR008859 | |
| Domain | TSP_C | 7.18e-06 | 5 | 169 | 3 | PF05735 | |
| Domain | Thrombospondin_3-like_rpt | 7.18e-06 | 5 | 169 | 3 | IPR003367 | |
| Domain | Alpha_kinase | 1.43e-05 | 6 | 169 | 3 | PF02816 | |
| Domain | MHCK_EF2_kinase | 1.43e-05 | 6 | 169 | 3 | IPR004166 | |
| Domain | ALPHA_KINASE | 1.43e-05 | 6 | 169 | 3 | PS51158 | |
| Domain | Alpha_kinase | 1.43e-05 | 6 | 169 | 3 | SM00811 | |
| Domain | EGF | 1.93e-05 | 126 | 169 | 8 | PF00008 | |
| Domain | LAM_G_DOMAIN | 2.25e-05 | 38 | 169 | 5 | PS50025 | |
| Domain | Laminin_G_2 | 2.91e-05 | 40 | 169 | 5 | PF02210 | |
| Domain | LamG | 4.67e-05 | 44 | 169 | 5 | SM00282 | |
| Domain | Storkhead-box_winged-helix | 8.14e-05 | 2 | 169 | 2 | IPR019391 | |
| Domain | HECW_N | 8.14e-05 | 2 | 169 | 2 | IPR032348 | |
| Domain | Stork_head | 8.14e-05 | 2 | 169 | 2 | PF10264 | |
| Domain | HECW_N | 8.14e-05 | 2 | 169 | 2 | PF16562 | |
| Domain | cEGF | 8.28e-05 | 26 | 169 | 4 | PF12662 | |
| Domain | cEGF | 8.28e-05 | 26 | 169 | 4 | IPR026823 | |
| Domain | ConA-like_dom | 1.76e-04 | 219 | 169 | 9 | IPR013320 | |
| Domain | G2F | 4.83e-04 | 4 | 169 | 2 | PF07474 | |
| Domain | NIDOGEN_G2 | 4.83e-04 | 4 | 169 | 2 | PS50993 | |
| Domain | GFP | 4.83e-04 | 4 | 169 | 2 | IPR009017 | |
| Domain | G2_nidogen/fibulin_G2F | 4.83e-04 | 4 | 169 | 2 | IPR006605 | |
| Domain | PH_dom-like | AGAP5 KIF1A KALRN PTPN13 NGEF PLCB3 AGAP9 AGAP7P ARHGEF26 AGAP4 AGAP6 EPB41 | 5.15e-04 | 426 | 169 | 12 | IPR011993 |
| Domain | CTCK_1 | 5.37e-04 | 18 | 169 | 3 | PS01185 | |
| Domain | WW | 8.52e-04 | 47 | 169 | 4 | PF00397 | |
| Domain | - | AGAP5 KIF1A KALRN PTPN13 NGEF PLCB3 AGAP9 ARHGEF26 AGAP4 AGAP6 EPB41 | 8.88e-04 | 391 | 169 | 11 | 2.30.29.30 |
| Domain | WW | 9.23e-04 | 48 | 169 | 4 | SM00456 | |
| Domain | CT | 9.88e-04 | 22 | 169 | 3 | SM00041 | |
| Domain | PH | 9.91e-04 | 278 | 169 | 9 | SM00233 | |
| Domain | PH_DOMAIN | 1.02e-03 | 279 | 169 | 9 | PS50003 | |
| Domain | PH_domain | 1.04e-03 | 280 | 169 | 9 | IPR001849 | |
| Domain | WW_DOMAIN_1 | 1.16e-03 | 51 | 169 | 4 | PS01159 | |
| Domain | WW_DOMAIN_2 | 1.16e-03 | 51 | 169 | 4 | PS50020 | |
| Domain | WW_dom | 1.25e-03 | 52 | 169 | 4 | IPR001202 | |
| Domain | Cys_knot_C | 1.45e-03 | 25 | 169 | 3 | IPR006207 | |
| Domain | CTCK_2 | 1.45e-03 | 25 | 169 | 3 | PS01225 | |
| Domain | HECT | 1.81e-03 | 27 | 169 | 3 | PF00632 | |
| Domain | HECTc | 1.81e-03 | 27 | 169 | 3 | SM00119 | |
| Domain | HECT_dom | 1.81e-03 | 27 | 169 | 3 | IPR000569 | |
| Domain | HECT | 1.81e-03 | 27 | 169 | 3 | PS50237 | |
| Domain | hEGF | 2.02e-03 | 28 | 169 | 3 | PF12661 | |
| Domain | CTLH | 2.81e-03 | 9 | 169 | 2 | SM00668 | |
| Pathway | REACTOME_ECM_PROTEOGLYCANS | 3.06e-05 | 76 | 112 | 6 | M27219 | |
| Pathway | KEGG_ECM_RECEPTOR_INTERACTION | 5.40e-05 | 84 | 112 | 6 | M7098 | |
| Pathway | REACTOME_EXTRACELLULAR_MATRIX_ORGANIZATION | 1.37e-04 | 300 | 112 | 10 | M610 | |
| Pubmed | 1.11e-13 | 7 | 177 | 6 | 8269511 | ||
| Pubmed | 1.44e-11 | 12 | 177 | 6 | 9598316 | ||
| Pubmed | 1.93e-11 | 6 | 177 | 5 | 15184870 | ||
| Pubmed | AGAP5 ZSCAN12 FNBP4 LAMA5 ICE1 KEAP1 ADNP NCAPH STOX2 DST ABCA5 HECW2 LRP4 AGAP9 AGAP7P AGAP4 AGAP6 ZNF646 MGRN1 | 3.55e-11 | 529 | 177 | 19 | 14621295 | |
| Pubmed | Degeneracy in human multicopy RBM (YRRM), a candidate spermatogenesis gene. | 6.72e-11 | 7 | 177 | 5 | 8875892 | |
| Pubmed | ZSCAN12 TCF20 HECW1 KALRN USP9X PPP1R9A RIPK2 KEAP1 ADNP ZBTB1 WDR47 STOX2 DST NRXN1 N4BP2 KIAA1217 NCAN NGEF ELAVL2 PRMT1 ARHGEF26 TNR PCM1 GOLGB1 | 1.58e-10 | 963 | 177 | 24 | 28671696 | |
| Pubmed | GGAPs, a new family of bifunctional GTP-binding and GTPase-activating proteins. | 4.00e-10 | 9 | 177 | 5 | 12640130 | |
| Pubmed | AGAP1/AP-3-dependent endocytic recycling of M5 muscarinic receptors promotes dopamine release. | 7.96e-10 | 10 | 177 | 5 | 20664521 | |
| Pubmed | 7.96e-10 | 10 | 177 | 5 | 9384609 | ||
| Pubmed | AGAP1, a novel binding partner of nitric oxide-sensitive guanylyl cyclase. | 1.45e-09 | 11 | 177 | 5 | 15381706 | |
| Pubmed | An RBM homologue maps to the mouse Y chromosome and is expressed in germ cells. | 3.23e-09 | 5 | 177 | 4 | 8817321 | |
| Pubmed | 3.23e-09 | 5 | 177 | 4 | 20016065 | ||
| Pubmed | The role of human and mouse Y chromosome genes in male infertility. | 3.23e-09 | 5 | 177 | 4 | 11097427 | |
| Pubmed | Rapid evolution of mouse Y centromere repeat DNA belies recent sequence stability. | 3.23e-09 | 5 | 177 | 4 | 19737860 | |
| Pubmed | 4.02e-09 | 13 | 177 | 5 | 27713690 | ||
| Pubmed | 6.22e-09 | 14 | 177 | 5 | 22453919 | ||
| Pubmed | Evolutionary strata on the mouse X chromosome correspond to strata on the human X chromosome. | 9.30e-09 | 15 | 177 | 5 | 14762062 | |
| Pubmed | Identification of target messenger RNA substrates for mouse RBMY. | 9.65e-09 | 6 | 177 | 4 | 18492746 | |
| Pubmed | Meiotic sex chromosome inactivation in male mice with targeted disruptions of Xist. | 9.65e-09 | 6 | 177 | 4 | 12356914 | |
| Pubmed | 9.65e-09 | 6 | 177 | 4 | 9499427 | ||
| Pubmed | 9.65e-09 | 6 | 177 | 4 | 18239052 | ||
| Pubmed | 9.65e-09 | 6 | 177 | 4 | 15051956 | ||
| Pubmed | The TRIM9/TRIM67 neuronal interactome reveals novel activators of morphogenesis. | AGAP5 KIF1A KALRN AZI2 CBLB STOX2 AGAP9 AGAP7P AGAP4 AGAP6 PCM1 | 1.79e-08 | 218 | 177 | 11 | 33378226 |
| Pubmed | A central chaperone-like role for 14-3-3 proteins in human cells. | EHBP1 AFTPH TCF20 CEP85L KCTD8 RIPK2 PARD3B FAM117B ALPK1 ARFGEF3 STOX2 PTPN13 DST RESF1 N4BP2 KIAA1217 COBL EPB41 PCM1 GOLGB1 | 1.92e-08 | 861 | 177 | 20 | 36931259 |
| Pubmed | The roles of RNA-binding proteins in spermatogenesis and male infertility. | 2.24e-08 | 7 | 177 | 4 | 10377282 | |
| Pubmed | 2.24e-08 | 7 | 177 | 4 | 17001072 | ||
| Pubmed | Sex differences in sex chromosome gene expression in mouse brain. | 2.62e-08 | 18 | 177 | 5 | 12023983 | |
| Pubmed | EHBP1 TCF20 ZSCAN4 ICE1 KEAP1 ADNP ZBTB1 ZNF8 PTPN13 DST RESF1 N4BP2 PCM1 GOLGB1 | 3.59e-08 | 418 | 177 | 14 | 34709266 | |
| Pubmed | ZSWIM8 RELN KIF1A KALRN CNST CEP85L USP9X CRTAC1 SPOCK2 NCKAP5 SHROOM2 WDR47 PTPN13 FBN1 DST ZNF660 NGEF NAV3 LRP4 PDZD8 USPL1 TXLNG BTRC PCM1 | 4.29e-08 | 1285 | 177 | 24 | 35914814 | |
| Pubmed | 4.47e-08 | 8 | 177 | 4 | 7479793 | ||
| Pubmed | Pathological Significance and Prognostic Roles of Thrombospondin-3, 4 and 5 in Bladder Cancer. | 1.30e-07 | 3 | 177 | 3 | 33910854 | |
| Pubmed | 1.33e-07 | 10 | 177 | 4 | 10601091 | ||
| Pubmed | The role of Dby mRNA in early development of male mouse zygotes. | 3.11e-07 | 12 | 177 | 4 | 20543856 | |
| Pubmed | AGAP5 USP9X KCTD8 STOX1 WDR47 PTPN13 NCAN ELAVL2 AGAP9 AGAP7P TNR AGAP4 AGAP6 | 3.61e-07 | 430 | 177 | 13 | 32581705 | |
| Pubmed | GASZ promotes germ cell derivation from embryonic stem cells. | 4.47e-07 | 13 | 177 | 4 | 23816659 | |
| Pubmed | 4.47e-07 | 13 | 177 | 4 | 10749975 | ||
| Pubmed | Absence of mDazl produces a final block on germ cell development at meiosis. | 6.24e-07 | 14 | 177 | 4 | 14611631 | |
| Pubmed | EHBP1 RBMY1A1 FAM114A2 GPATCH4 KEAP1 CHORDC1 TRAPPC8 NDRG3 SLIT2 EDEM3 PTPN13 MAVS GORAB PDZD8 N4BP1 TXLNG EPB41 PCM1 GOLGB1 | 1.05e-06 | 1007 | 177 | 19 | 34597346 | |
| Pubmed | Protein interactome reveals converging molecular pathways among autism disorders. | ZSWIM8 HECW1 MYO5B WWP1 LAMA5 SLIT2 FBLN1 FBN1 SLIT1 COBL PRMT1 KAZN AGAP7P USPL1 | 1.22e-06 | 560 | 177 | 14 | 21653829 |
| Pubmed | 1.29e-06 | 5 | 177 | 3 | 30622267 | ||
| Pubmed | 1.29e-06 | 5 | 177 | 3 | 18467703 | ||
| Pubmed | Loss of maternal Trim28 causes male-predominant early embryonic lethality. | 1.47e-06 | 17 | 177 | 4 | 28115466 | |
| Pubmed | EHBP1 HECW1 MYO5B ALPK1 TRAPPC8 RALGAPA2 RGL1 NPHP3 N4BP2 SOCS5 N4BP1 KAZN UNC80 | 1.66e-06 | 493 | 177 | 13 | 15368895 | |
| Pubmed | Synaptic GAP and GEF Complexes Cluster Proteins Essential for GTP Signaling. | 1.98e-06 | 281 | 177 | 10 | 28706196 | |
| Pubmed | Genome-wide CRISPR screen identifies HNRNPL as a prostate cancer dependency regulating RNA splicing. | EHBP1 KIF1A WWP1 PPP1R9A FNBP4 PARD3B FAM117B SHROOM2 DNAH14 PCNX2 ARFGEF3 BPTF MALT1 PTPN13 LATS2 KIAA1217 NGEF COBL ARHGEF26 EPB41 PCM1 GOLGB1 MGRN1 | 2.24e-06 | 1489 | 177 | 23 | 28611215 |
| Pubmed | 2.30e-06 | 116 | 177 | 7 | 30652415 | ||
| Pubmed | 2.37e-06 | 19 | 177 | 4 | 21572392 | ||
| Pubmed | Alpha-kinases: a new class of protein kinases with a novel catalytic domain. | 2.56e-06 | 6 | 177 | 3 | 10021370 | |
| Pubmed | PCSK5 ZSWIM8 FAT4 GCFC2 HECW1 MYO5B KALRN WWP1 MAGEB18 UBR7 FBLN1 SLIT1 PRMT1 KAZN | 3.17e-06 | 608 | 177 | 14 | 16713569 | |
| Pubmed | 3.63e-06 | 21 | 177 | 4 | 37005481 | ||
| Pubmed | ZSWIM8 WWP1 GPATCH4 KEAP1 RALGAPA2 RNF43 ZNF711 ZNF8 SLIT2 EDEM3 BPTF MALT1 RESF1 HMCN2 LRP4 MMS19 UNC80 PCM1 ZNF646 | 4.67e-06 | 1116 | 177 | 19 | 31753913 | |
| Pubmed | 4.90e-06 | 130 | 177 | 7 | 12421765 | ||
| Pubmed | Comparative interactome analysis of α-arrestin families in human and Drosophila. | ZSWIM8 USP9X WWP1 LAMA5 ARFGEF3 SLIT2 PTPN13 NPHP3 HECW2 MMS19 | 5.16e-06 | 313 | 177 | 10 | 38270169 |
| Pubmed | Shotgun sequencing of the human transcriptome with ORF expressed sequence tags. | ZSWIM8 ZSCAN12 KIF1A KALRN USP9X ALPK1 ARFGEF3 SLIT2 ASXL3 ZNF335 MUC2 UNC80 PCM1 | 5.66e-06 | 552 | 177 | 13 | 10737800 |
| Pubmed | N-Terminal Acetyltransferase Naa40p Whereabouts Put into N-Terminal Proteoform Perspective. | EHBP1 AFTPH PARG FAM114A2 GPATCH4 ICE1 KEAP1 ADNP NCAPH PTPN13 DST MAVS KIAA1217 PRMT1 EPB41 PCM1 GOLGB1 | 6.42e-06 | 934 | 177 | 17 | 33916271 |
| Pubmed | Hdac4 Interactions in Huntington's Disease Viewed Through the Prism of Multiomics. | ZSWIM8 KIF1A KALRN USP9X SLIT2 SLIT1 NGEF NAV3 ELAVL2 PLCB3 BTRC PCM1 | 6.49e-06 | 475 | 177 | 12 | 31040226 |
| Pubmed | Thrombospondins 1 and 2 are important for afferent synapse formation and function in the inner ear. | 7.12e-06 | 8 | 177 | 3 | 24460873 | |
| Pubmed | PlexinA1 is a new Slit receptor and mediates axon guidance function of Slit C-terminal fragments. | 7.12e-06 | 8 | 177 | 3 | 25485759 | |
| Pubmed | 7.12e-06 | 8 | 177 | 3 | 16774856 | ||
| Pubmed | EHBP1 TCF20 NCKAP5 CBLB RGL1 DST N4BP2 NAV3 COBL ATF4 TXLNG GOLGB1 | 8.16e-06 | 486 | 177 | 12 | 20936779 | |
| Pubmed | The human cytoplasmic dynein interactome reveals novel activators of motility. | AFTPH CEP85L TUT7 PKD1L1 PARD3B AZI2 CHORDC1 MAVS IQCC N4BP2 KIAA1217 COBL TXLNG CEP97 EPB41 PCM1 | 8.38e-06 | 853 | 177 | 16 | 28718761 |
| Pubmed | 8.88e-06 | 26 | 177 | 4 | 35920200 | ||
| Pubmed | 8.93e-06 | 263 | 177 | 9 | 34702444 | ||
| Pubmed | Lineage-specific biology revealed by a finished genome assembly of the mouse. | 9.13e-06 | 55 | 177 | 5 | 19468303 | |
| Pubmed | 9.53e-06 | 95 | 177 | 6 | 24029230 | ||
| Pubmed | EHBP1 PPP1R9A PARD3B RALGAPA2 CBLB PTPN13 DST KIAA1217 GORAB COBL GOLGB1 | 1.16e-05 | 421 | 177 | 11 | 36976175 | |
| Pubmed | PAPPA2 RMND5A RNF168 TCF21 ZSCAN4 WWP1 FNBP4 LAMA5 KEAP1 CBLB FBLN1 DST GOLGB1 | 1.17e-05 | 591 | 177 | 13 | 15231748 | |
| Pubmed | 1.27e-05 | 209 | 177 | 8 | 36779422 | ||
| Pubmed | AGAP5 FAT4 MINDY2 DST TCP11L2 ASXL3 KIAA1217 AGAP7P USPL1 SPAG17 AGAP4 ALPK2 | 1.40e-05 | 513 | 177 | 12 | 25798074 | |
| Pubmed | 1.43e-05 | 102 | 177 | 6 | 10231032 | ||
| Pubmed | 2.51e-05 | 167 | 177 | 7 | 22159717 | ||
| Pubmed | Diagnostic value of serum COMP and ADAMTS7 for intervertebral disc degeneration. | 2.58e-05 | 2 | 177 | 2 | 38528617 | |
| Pubmed | Upregulation of ADAMTS‑7 and downregulation of COMP are associated with aortic aneurysm. | 2.58e-05 | 2 | 177 | 2 | 28849199 | |
| Pubmed | 2.58e-05 | 2 | 177 | 2 | 16585064 | ||
| Pubmed | FIAT represses ATF4-mediated transcription to regulate bone mass in transgenic mice. | 2.58e-05 | 2 | 177 | 2 | 15911876 | |
| Pubmed | Association between Genetic Polymorphisms of Inflammatory Response Genes and Acute Pancreatitis. | 2.58e-05 | 2 | 177 | 2 | 31044631 | |
| Pubmed | 2.58e-05 | 2 | 177 | 2 | 11137453 | ||
| Pubmed | COMP and TSP-4 interact specifically with the novel GXKGHR motif only found in fibrillar collagens. | 2.58e-05 | 2 | 177 | 2 | 30464261 | |
| Pubmed | Potential dual functional roles of the Y-linked RBMY in hepatocarcinogenesis. | 2.58e-05 | 2 | 177 | 2 | 32473614 | |
| Pubmed | 2.58e-05 | 2 | 177 | 2 | 12515855 | ||
| Pubmed | Slit proteins: molecular guidance cues for cells ranging from neurons to leukocytes. | 2.58e-05 | 2 | 177 | 2 | 12200164 | |
| Pubmed | Mammalian hemicentin 1 is assembled into tracks in the extracellular matrix of multiple tissues. | 2.58e-05 | 2 | 177 | 2 | 32035013 | |
| Pubmed | PRMT1 suppresses ATF4-mediated endoplasmic reticulum response in cardiomyocytes. | 2.58e-05 | 2 | 177 | 2 | 31787756 | |
| Pubmed | Directional guidance of neuronal migration in the olfactory system by the protein Slit. | 2.58e-05 | 2 | 177 | 2 | 10432110 | |
| Pubmed | 2.58e-05 | 2 | 177 | 2 | 38064597 | ||
| Pubmed | 2.58e-05 | 2 | 177 | 2 | 20643876 | ||
| Pubmed | Lymph node CEA and MUC2 mRNA as useful predictors of outcome in colorectal cancer. | 2.58e-05 | 2 | 177 | 2 | 21618511 | |
| Pubmed | Upregulation of ADAMTS‑7 and downregulation of COMP are associated with spontaneous abortion. | 2.58e-05 | 2 | 177 | 2 | 30720083 | |
| Pubmed | 2.58e-05 | 2 | 177 | 2 | 37028586 | ||
| Pubmed | 2.58e-05 | 2 | 177 | 2 | 23320558 | ||
| Pubmed | Slit1 and slit2 proteins control the development of the lateral olfactory tract. | 2.58e-05 | 2 | 177 | 2 | 12097499 | |
| Pubmed | N4BP1 restricts HIV-1 and its inactivation by MALT1 promotes viral reactivation. | 2.58e-05 | 2 | 177 | 2 | 31133753 | |
| Pubmed | 2.76e-05 | 12 | 177 | 3 | 16540508 | ||
| Pubmed | 3.20e-05 | 71 | 177 | 5 | 33541421 | ||
| Pubmed | 3.38e-05 | 175 | 177 | 7 | 28071719 | ||
| Pubmed | The Functional Proximal Proteome of Oncogenic Ras Includes mTORC2. | EHBP1 WWP1 PPP1R9A RALGAPA2 NDRG3 LATS2 COBL PLCB3 ARHGEF26 TXLNG PLXNA1 EPB41 | 3.84e-05 | 569 | 177 | 12 | 30639242 |
| Pubmed | An improved smaller biotin ligase for BioID proximity labeling. | 4.14e-05 | 123 | 177 | 6 | 26912792 | |
| Pubmed | A dual-activity topoisomerase complex regulates mRNA translation and turnover. | MYCL PCSK5 KALRN WWP1 LAMA5 ICE1 RALGAPA2 RNF43 PCNX2 DST LATS2 ADAMTS7 ZNF335 LRP4 PDZD8 COBL PLXNA1 | 5.39e-05 | 1105 | 177 | 17 | 35748872 |
| Pubmed | Hundreds of variants clustered in genomic loci and biological pathways affect human height. | 7.38e-05 | 198 | 177 | 7 | 20881960 | |
| Pubmed | 7.70e-05 | 3 | 177 | 2 | 12388743 | ||
| Interaction | ILDR1 interactions | 1.77e-06 | 11 | 176 | 4 | int:ILDR1 | |
| Cytoband | Yq11.223 | 3.18e-05 | 93 | 177 | 5 | Yq11.223 | |
| Cytoband | 10q11.23 | 2.82e-04 | 33 | 177 | 3 | 10q11.23 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr1q25 | 4.96e-04 | 167 | 177 | 5 | chr1q25 | |
| Cytoband | 4q21.3 | 7.95e-04 | 11 | 177 | 2 | 4q21.3 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr10q11 | 8.46e-04 | 188 | 177 | 5 | chr10q11 | |
| Cytoband | 8q21 | 9.51e-04 | 12 | 177 | 2 | 8q21 | |
| GeneFamily | ArfGAPs | 1.58e-06 | 33 | 110 | 5 | 395 | |
| GeneFamily | X-linked mental retardation|Rho GTPase activating proteins|BAR-PH domain containing | 2.90e-06 | 17 | 110 | 4 | 1291 | |
| GeneFamily | Fibulins | 1.20e-05 | 8 | 110 | 3 | 556 | |
| GeneFamily | Pleckstrin homology domain containing|Rho guanine nucleotide exchange factors|C2 domain containing | 2.66e-04 | 206 | 110 | 7 | 682 | |
| GeneFamily | RNA binding motif containing | 3.26e-04 | 213 | 110 | 7 | 725 | |
| GeneFamily | PDZ domain containing | 2.37e-03 | 152 | 110 | 5 | 1220 | |
| GeneFamily | Blood group antigens|CD molecules|I-set domain containing|Immunoglobulin like domain containing | 3.04e-03 | 161 | 110 | 5 | 593 | |
| Coexpression | NABA_CORE_MATRISOME | RELN COMP DSPP LAMA5 SPOCK2 SLIT2 FBLN1 THBS3 THBS4 FBN1 HMCN2 HMCN1 NCAN SLIT1 TNR | 4.44e-10 | 270 | 175 | 15 | MM17057 |
| Coexpression | NABA_ECM_GLYCOPROTEINS | RELN COMP DSPP LAMA5 SLIT2 FBLN1 THBS3 THBS4 FBN1 HMCN2 HMCN1 SLIT1 TNR | 5.68e-10 | 191 | 175 | 13 | MM17059 |
| Coexpression | NABA_CORE_MATRISOME | RELN COMP DSPP LAMA5 SPOCK2 SLIT2 FBLN1 THBS3 THBS4 FBN1 HMCN2 HMCN1 NCAN SLIT1 TNR | 5.72e-10 | 275 | 175 | 15 | M5884 |
| Coexpression | NABA_ECM_GLYCOPROTEINS | RELN COMP DSPP LAMA5 SLIT2 FBLN1 THBS3 THBS4 FBN1 HMCN2 HMCN1 SLIT1 TNR | 7.81e-10 | 196 | 175 | 13 | M3008 |
| Coexpression | MANNO_MIDBRAIN_NEUROTYPES_HGABA | RELN KIF1A CEP85L PPP1R9A LAMA5 FAM114A2 SPOCK2 FAM117B SHROOM2 ARFGEF3 STOX2 NRXN1 N4BP2 ASXL3 NCAN NGEF NAV3 ELAVL2 EEA1 SPAG17 MUC2 PLXNA1 EPB41 CALN1 CCDC144A | 9.77e-08 | 1106 | 175 | 25 | M39071 |
| Coexpression | NABA_MATRISOME | PAPPA2 PCSK5 RELN COMP DSPP LAMA5 SPOCK2 CLEC4M SLIT2 FBLN1 THBS3 THBS4 FBN1 HMCN2 HMCN1 ADAMTS7 BTC NCAN SLIT1 MUC2 TNR PLXNA1 | 1.10e-06 | 1008 | 175 | 22 | MM17056 |
| Coexpression | NABA_MATRISOME | PAPPA2 PCSK5 RELN COMP DSPP LAMA5 SPOCK2 CLEC4M SLIT2 FBLN1 THBS3 THBS4 FBN1 HMCN2 HMCN1 ADAMTS7 BTC NCAN SLIT1 MUC2 TNR PLXNA1 | 1.47e-06 | 1026 | 175 | 22 | M5889 |
| Coexpression | DACOSTA_UV_RESPONSE_VIA_ERCC3_XPCS_DN | 1.67e-06 | 85 | 175 | 7 | M10575 | |
| Coexpression | THEODOROU_MAMMARY_TUMORIGENESIS | 4.59e-06 | 37 | 175 | 5 | MM1121 | |
| Coexpression | DACOSTA_UV_RESPONSE_VIA_ERCC3_DN | EHBP1 AVL9 USP9X WWP1 PARG TRAPPC8 ADNP CBLB SLIT2 BPTF RGL1 MALT1 PTPN13 DST SOCS5 NAV3 N4BP1 KAZN BTRC | 4.95e-06 | 856 | 175 | 19 | M4500 |
| Coexpression | GAUSSMANN_MLL_AF4_FUSION_TARGETS_F_DN | 1.10e-05 | 44 | 175 | 5 | MM485 | |
| Coexpression | CUI_TCF21_TARGETS_2_DN | TCF21 CEP85L USP9X TUT7 PARD3B ADGRE2 CBLB SHROOM2 MINDY2 ARFGEF3 EDEM3 MALT1 DST LATS2 TCP11L2 ABCA5 HECW2 ARHGEF26 | 2.98e-05 | 888 | 175 | 18 | MM1018 |
| Coexpression | HAMAI_APOPTOSIS_VIA_TRAIL_UP | PCSK5 USP9X WWP1 TUT7 CHORDC1 TRAPPC8 BPTF STOX2 PTPN13 RESF1 ABCA5 EEA1 ZNF654 PCM1 GOLGB1 | 3.68e-05 | 656 | 175 | 15 | M18979 |
| Coexpression | BUSSLINGER_GASTRIC_G_CELLS | 5.15e-05 | 98 | 175 | 6 | M40018 | |
| Coexpression | BROWNE_HCMV_INFECTION_30MIN_DN | 5.58e-05 | 145 | 175 | 7 | M0 | |
| Coexpression | CUI_TCF21_TARGETS_2_DN | TCF21 CEP85L USP9X TUT7 PARD3B CBLB SHROOM2 MINDY2 ARFGEF3 EDEM3 MALT1 DST LATS2 TCP11L2 ABCA5 HECW2 ARHGEF26 | 6.25e-05 | 854 | 175 | 17 | M1533 |
| Coexpression | GSE19941_IL10_KO_VS_IL10_KO_AND_NFKBP50_KO_UNSTIM_MACROPHAGE_DN | 6.25e-05 | 200 | 175 | 8 | M8110 | |
| Coexpression | GSE13411_SWITCHED_MEMORY_BCELL_VS_PLASMA_CELL_UP | 6.25e-05 | 200 | 175 | 8 | M3251 | |
| Coexpression | GSE29618_PRE_VS_DAY7_POST_LAIV_FLU_VACCINE_MONOCYTE_DN | 6.25e-05 | 200 | 175 | 8 | M4994 | |
| Coexpression | GSE5589_LPS_VS_LPS_AND_IL10_STIM_IL10_KO_MACROPHAGE_45MIN_UP | 6.25e-05 | 200 | 175 | 8 | M6629 | |
| Coexpression | GSE360_HIGH_VS_LOW_DOSE_B_MALAYI_MAC_UP | 6.25e-05 | 200 | 175 | 8 | M5261 | |
| Coexpression | CHEN_ETV5_TARGETS_TESTIS | 6.75e-05 | 33 | 175 | 4 | MM701 | |
| Coexpression | ACEVEDO_METHYLATED_IN_LIVER_CANCER_DN | KIF1A KALRN C6orf89 NAA11 RBMY1A1 TUT7 RBMY1D RBMY1B RBMY1E CRTAC1 MALT1 ZNF660 RBMY1F PDZD8 KAZN BTRC CALN1 | 8.17e-05 | 873 | 175 | 17 | M16009 |
| Coexpression | KARLSSON_TGFB1_TARGETS_DN | 8.50e-05 | 209 | 175 | 8 | MM1058 | |
| Coexpression | GSE7768_OVA_ALONE_VS_OVA_WITH_MPL_IMMUNIZED_MOUSE_WHOLE_SPLEEN_6H_DN | 1.21e-04 | 164 | 175 | 7 | M6859 | |
| Coexpression | BUYTAERT_PHOTODYNAMIC_THERAPY_STRESS_UP | RELN RMND5A TCF20 RIPK2 FNBP4 AZI2 CHORDC1 CBLB WDR47 RGL1 DST RESF1 N4BP1 ATF4 USPL1 GOLGB1 | 1.34e-04 | 822 | 175 | 16 | M6782 |
| Coexpression | LAKE_ADULT_KIDNEY_C4_PROXIMAL_TUBULE_EPITHELIAL_CELLS_S2 | 1.87e-04 | 176 | 175 | 7 | M39223 | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-thymocyte|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | FAT4 RELN HECW1 KALRN ODAD2 ARFGEF3 HMCN1 NRXN1 ASXL3 NAV3 SPAG17 UNC80 | 9.35e-12 | 184 | 174 | 12 | 2cbed6462fea2622871bb7e49b0df3d984239281 |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | FAT4 RELN HECW1 KALRN ODAD2 ARFGEF3 HMCN1 NRXN1 ASXL3 NAV3 SPAG17 UNC80 | 9.35e-12 | 184 | 174 | 12 | ea7a7e2bac46d4d2c31a5d576b38a032b5335062 |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-proliferating_thymocyte;_DN_to_DP_transition,_dividing_(some_are_Cd8+/_Cd4+,_some_undergoing_VDJ_recombination)|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | FAT4 RELN HECW1 KALRN ODAD2 ARFGEF3 HMCN1 NRXN1 ASXL3 NAV3 SPAG17 UNC80 | 9.35e-12 | 184 | 174 | 12 | 2b19a8c5f823e00812908b23e66bb4e563278aff |
| ToppCell | Fetal_29-31_weeks-Mesenchymal|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | FAT4 PDE3A TCF21 KALRN LDLRAD3 SLIT2 FBLN1 FBN1 DST HMCN1 KAZN | 3.90e-10 | 198 | 174 | 11 | 21cf4d81386761d09d0f6829c01c198e5524176d |
| ToppCell | COVID-19-Fibroblasts-Other_FB|COVID-19 / group, cell type (main and fine annotations) | 4.89e-09 | 193 | 174 | 10 | e6b75be08e33c1de079fb5c02f0b4468128b369c | |
| ToppCell | Fetal_29-31_weeks-Mesenchymal-matrix_fibroblast_1_cell|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 5.14e-09 | 194 | 174 | 10 | 011e14d9ed1393275f892060e7708ffadcd0767f | |
| ToppCell | nucseq-Epithelial-Epithelial_Alveolar|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | MYO5B PPP1R9A PARD3B NCKAP5 DNAH14 ARFGEF3 STOX2 PTPN13 COBL ARHGEF26 | 5.14e-09 | 194 | 174 | 10 | 53f3e49e91b1096f3226010e2de767efb490dfe4 |
| ToppCell | Mesenchymal|World / Lineage, Cell type, age group and donor | 6.56e-09 | 199 | 174 | 10 | 4bac110c2b3609f6ee5d0e3275da0824a6240270 | |
| ToppCell | nucseq-Epithelial-Epithelial_Alveolar-AT1-AT1|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 4.81e-08 | 184 | 174 | 9 | 57c792e6e2fedba25d3350ffe649fd74750b579d | |
| ToppCell | nucseq-Epithelial-Epithelial_Alveolar-AT1|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 4.81e-08 | 184 | 174 | 9 | d7bd0f0c607bade67c99e9fb3578a570298bf926 | |
| ToppCell | COPD-Epithelial-Club|World / Disease state, Lineage and Cell class | MYO5B PPP1R9A PARD3B CRTAC1 NCKAP5 ARFGEF3 PTPN13 KIAA1217 COBL | 5.28e-08 | 186 | 174 | 9 | 3006f4ab1eaf1eb34c10ca9f7c869603d2d25744 |
| ToppCell | Control-Fibroblasts-Other_FB|Control / group, cell type (main and fine annotations) | 5.53e-08 | 187 | 174 | 9 | bd3739c4a52aa1ba5deffd778e113a9800f7e158 | |
| ToppCell | Adult-Epithelial|Adult / Lineage, Cell type, age group and donor | MYO5B PPP1R9A PARD3B DNAH14 ARFGEF3 STOX2 PTPN13 KIAA1217 COBL | 6.93e-08 | 192 | 174 | 9 | efb962a5fd3b9bdfd8cf8d13c435e29c8271713e |
| ToppCell | LA-02._Fibroblast_II|World / Chamber and Cluster_Paper | 7.91e-08 | 195 | 174 | 9 | a78b605b49acd8c9d68716266ca269dafcd910b9 | |
| ToppCell | nucseq-Epithelial|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | MYO5B PPP1R9A PARD3B NCKAP5 DNAH14 ARFGEF3 STOX2 PTPN13 COBL | 7.91e-08 | 195 | 174 | 9 | 9406866f99555198a9be311fbd65751b70f35446 |
| ToppCell | droplet-Pancreas-PANCREAS-30m-Epithelial-pancreatic_B_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.91e-08 | 195 | 174 | 9 | 7796ea9247f4c63762f0de8490fed08b9717fa23 | |
| ToppCell | COVID-19-Fibroblasts|COVID-19 / group, cell type (main and fine annotations) | 8.63e-08 | 197 | 174 | 9 | fb847f2277609c31fffcdf49517243ce0684facf | |
| ToppCell | background-Hepatic_Stellate_cells|background / Sample and Cell Type and Tumor Cluster (all cells) | 9.01e-08 | 198 | 174 | 9 | bd11b0e9e80449aab979a02c1023e0638c431c7c | |
| ToppCell | Smart-start-Cell-Wel_seq-Non-neoplastic-Glial-Neuronal-OPC-OPC-G|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 9.41e-08 | 199 | 174 | 9 | 19a97e27a4758e794ce7246d295e112b47931a48 | |
| ToppCell | LPS_IL1RA-Endothelial-Endothelial-Gen_Cap|LPS_IL1RA / Treatment groups by lineage, cell group, cell type | 9.82e-08 | 200 | 174 | 9 | dccec522ab0d7fff62ad6273b02aa9022dbbb8eb | |
| ToppCell | Tracheal-NucSeq-Epithelial-Epi_submucosal-gland|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | MYO5B PPP1R9A SLC12A8 ITPRID1 RALGAPA2 ARFGEF3 STOX2 KIAA1217 COBL | 9.82e-08 | 200 | 174 | 9 | 0eb9ad8c0373bcc62029ec21c590ed03aaacd039 |
| ToppCell | Control|World / group, cell type (main and fine annotations) | 3.34e-07 | 168 | 174 | 8 | a3511faf2cd2c2b9c8363c8b99da3f3609c43ed6 | |
| ToppCell | COVID-19-Epithelial_cells-AT1|COVID-19 / group, cell type (main and fine annotations) | 5.42e-07 | 179 | 174 | 8 | a0b33bd69ffdfd5d38d80207fb40058a490aa19e | |
| ToppCell | COVID-19-Endothelial_cells-Capillary_endothelial_cells|COVID-19 / group, cell type (main and fine annotations) | 5.89e-07 | 181 | 174 | 8 | c5f9c92af1384d9089c65afdf41c6feb8345a3ae | |
| ToppCell | COVID-19-lung-AT1|lung / Disease (COVID-19 only), tissue and cell type | 6.40e-07 | 183 | 174 | 8 | 942530449e9c6583705eeb8f6f12621daea57252 | |
| ToppCell | TCGA-Pancreas-Primary_Tumor-Pancreatic_Adenocarcinoma-Ductal_Adenocarcinoma-4|TCGA-Pancreas / Sample_Type by Project: Shred V9 | 6.67e-07 | 184 | 174 | 8 | 67164bb6bcae7322cb89b585c7aa10bce35b0ecd | |
| ToppCell | 343B-Epithelial_cells-Epithelial-I_(AT1)|343B / Donor, Lineage, Cell class and subclass (all cells) | 6.67e-07 | 184 | 174 | 8 | cb15d6bae52c5ec251c2235859dc7e65f630ae23 | |
| ToppCell | 343B-Epithelial_cells-Epithelial-I_(AT1)-|343B / Donor, Lineage, Cell class and subclass (all cells) | 6.67e-07 | 184 | 174 | 8 | bde4eaabd3e9bdaed23867d23a919b9d84b52d4b | |
| ToppCell | Children_(3_yrs)-Epithelial-alveolar_epithelial_cell_type_1|Children_(3_yrs) / Lineage, Cell type, age group and donor | 6.95e-07 | 185 | 174 | 8 | 1c222f7285d6e3dae0354dc7e853ddc0ea55e63e | |
| ToppCell | PCW_10-12-Mesenchymal-Mesenchymal_fibroblastic-mes_immature_COL13A1^pos_fibro2_(5)|PCW_10-12 / Celltypes from embryonic and fetal-stage human lung | 6.95e-07 | 185 | 174 | 8 | 9f19f04fc4d97dfc2dd78cde77b515f1cb5d51ec | |
| ToppCell | Epithelial-alveolar_epithelial_cell_type_1|World / Lineage, Cell type, age group and donor | 7.24e-07 | 186 | 174 | 8 | 09d95daa3387a4814cffaa4b798cc2810c3759d0 | |
| ToppCell | LA-01._Fibroblast_I|World / Chamber and Cluster_Paper | 7.54e-07 | 187 | 174 | 8 | 4ea486991f66c29728d127171a07b81404ec0b78 | |
| ToppCell | Children_(3_yrs)-Epithelial-alveolar_epithelial_cell_type_1-D139|Children_(3_yrs) / Lineage, Cell type, age group and donor | 7.54e-07 | 187 | 174 | 8 | d4b0afd9b92c47c8aa348bbd1af7eb54c3d478f2 | |
| ToppCell | Adult-Epithelial-alveolar_epithelial_cell_type_1|Adult / Lineage, Cell type, age group and donor | 7.54e-07 | 187 | 174 | 8 | 77f78aec946bc6bd85c29aee9ca978ce49f853a3 | |
| ToppCell | renal_papilla_nuclei-Adult_normal_reference-Mesenchymal-Fibroblast-Collagen-low_Matrisome-low_fibroblast-|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 8.84e-07 | 191 | 174 | 8 | c54c420a94dc749ebc67fc64c5614663f4b9798d | |
| ToppCell | facs-Pancreas-Endocrine-24m-Epithelial-pancreatic_B_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 8.84e-07 | 191 | 174 | 8 | 3387b95a3f2445c672d407922fdce3a91eabaef8 | |
| ToppCell | renal_papilla_nuclei-Adult_normal_reference-Mesenchymal-Fibroblast-Collagen-low_Matrisome-low_fibroblast|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 8.84e-07 | 191 | 174 | 8 | cb0aee740b08f7d5fdd2717ecf7429043b277ae7 | |
| ToppCell | Epithelial-alveolar_epithelial_cell_type_1/2_(AT1/AT2-like)|World / Lineage, Cell type, age group and donor | 8.84e-07 | 191 | 174 | 8 | d3733c8c4bda70c4390e5601fdda6188a64be944 | |
| ToppCell | Children_(3_yrs)-Epithelial|Children_(3_yrs) / Lineage, Cell type, age group and donor | 8.84e-07 | 191 | 174 | 8 | e432c6e1ae82dddf84314ce73d2b7a991630d905 | |
| ToppCell | nucseq-Mesenchymal-Fibroblastic-Fibroblastic_2-AF1|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 8.84e-07 | 191 | 174 | 8 | 6688cee34beee4f151ac17fccbc9c26a9aad72e1 | |
| ToppCell | Epithelial|World / Lineage, Cell type, age group and donor | 9.19e-07 | 192 | 174 | 8 | 499e8893afea5e6d3371e0bd018f7e86a524d669 | |
| ToppCell | Control-Endothelial-Endothelial-Gen_Cap|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 9.56e-07 | 193 | 174 | 8 | e1d546165dcc2392f540162206852c4717d7306f | |
| ToppCell | LA|World / Chamber and Cluster_Paper | 9.56e-07 | 193 | 174 | 8 | d4bf89437216baf489ea0239136dcedf3b6714af | |
| ToppCell | Mesenchymal-matrix_fibroblast_1_cell|World / Lineage, Cell type, age group and donor | 9.56e-07 | 193 | 174 | 8 | acad568621ed677031797b8c2e34dafea798d681 | |
| ToppCell | Fetal_29-31_weeks-Epithelial|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 9.56e-07 | 193 | 174 | 8 | a0ca3231992f14abcf1a6129573bace320e89d2a | |
| ToppCell | Smart-seq2-spleen_(Smart-seq2)-myeloid-myeloid_granulocytic-neutrophil|spleen_(Smart-seq2) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 1.03e-06 | 195 | 174 | 8 | d3755929ebbbf5e3afde44281e9056ddb614a291 | |
| ToppCell | 356C-Epithelial_cells-Epithelial-I_(AT1)|356C / Donor, Lineage, Cell class and subclass (all cells) | 1.03e-06 | 195 | 174 | 8 | 07a3ef6b0f1201fe2bcb9ea426b8f7a69beb4904 | |
| ToppCell | Smart-seq2-spleen_(Smart-seq2)-myeloid-myeloid_granulocytic|spleen_(Smart-seq2) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 1.03e-06 | 195 | 174 | 8 | 19853c654ac64b3ae3bc99841c6cb29c8aaba85c | |
| ToppCell | Adult-Mesenchymal-matrix_fibroblast_1_cell|Adult / Lineage, Cell type, age group and donor | 1.03e-06 | 195 | 174 | 8 | 61c9e09fc84d1012e472185d70ad0a06cee30d6e | |
| ToppCell | COVID-19-Fibroblasts-Alveolar_FB|COVID-19 / group, cell type (main and fine annotations) | 1.03e-06 | 195 | 174 | 8 | 603050beeb33c331d4b2e3fa46cae3f3e0e4bdc7 | |
| ToppCell | 356C-Epithelial_cells-Epithelial-I_(AT1)-|356C / Donor, Lineage, Cell class and subclass (all cells) | 1.03e-06 | 195 | 174 | 8 | b65511770ed67f7447847e2187555b362988af45 | |
| ToppCell | droplet-Pancreas-PANCREAS-30m-Epithelial-pancreatic_B_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.03e-06 | 195 | 174 | 8 | 3e519cffa6144a62b06124642a14c9ff39b76554 | |
| ToppCell | (7)_Epithelial-I_(AT1)|World / Lung cell shreds - cell class (v4) and cell subclass (v4) | 1.07e-06 | 196 | 174 | 8 | 150554fa06868d29b0608189862eef6505ba757f | |
| ToppCell | Tracheal-NucSeq-Stromal-Fibroblastic-Fibro_myofibroblast|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 1.12e-06 | 197 | 174 | 8 | 0dd71e399f253787fa546a7e90c5373180b89ffd | |
| ToppCell | COVID-19-Fibroblasts-Intermediate_pathological_FB|COVID-19 / group, cell type (main and fine annotations) | 1.12e-06 | 197 | 174 | 8 | f1c8936986123a3151140c374fcd62d6705c530b | |
| ToppCell | Parenchymal-NucSeq-Epithelial-Epi_alveolar-AT1|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 1.12e-06 | 197 | 174 | 8 | 8d5097898dd01cedb04cb694cb480c931e08462c | |
| ToppCell | ASK428-Epithelial-Type_1|ASK428 / Donor, Lineage and Cell class of Lung cells from Dropseq | 1.12e-06 | 197 | 174 | 8 | 9ae6661c307791c3f0ecd3d378e3d917565e5498 | |
| ToppCell | PCW_10-12-Mesenchymal-Mesenchymal_fibroblastic-mes_immature1_(0)|PCW_10-12 / Celltypes from embryonic and fetal-stage human lung | 1.12e-06 | 197 | 174 | 8 | 11a4c417f035e554431a8f03be13b5eefa3530c0 | |
| ToppCell | Parenchymal-10x5prime-Stromal-Fibroblastic-Fibro_peribronchial|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 1.16e-06 | 198 | 174 | 8 | 300d7cc56207d77168390fa1ffcbcf76767b1b80 | |
| ToppCell | Epithelial_cells-AT1-AT2_cells|Epithelial_cells / lung cells shred on cell class, cell subclass, sample id | 1.16e-06 | 198 | 174 | 8 | fbc46b20bcd44f2083170aacbc6f5dd00fba685c | |
| ToppCell | ASK428-Epithelial-Type_1|Epithelial / Donor, Lineage and Cell class of Lung cells from Dropseq | 1.16e-06 | 198 | 174 | 8 | 0047a9ef7684230ac5179efea94461480e90bdaf | |
| ToppCell | Parenchymal-NucSeq-Epithelial|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 1.20e-06 | 199 | 174 | 8 | 5cea0d9e261903e0eaad60c28a07dff72ce65027 | |
| ToppCell | medial-2-mesenchymal-Myofibroblast|2 / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 1.20e-06 | 199 | 174 | 8 | 95aae608fa35a9c82b12c6f18937ce636750ca44 | |
| ToppCell | medial-mesenchymal-Myofibroblast|medial / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 1.20e-06 | 199 | 174 | 8 | e25acdb5809aaff631cb06dbe4c7e59549a0bdb9 | |
| ToppCell | medial-mesenchymal-Myofibroblast-2|medial / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 1.20e-06 | 199 | 174 | 8 | 9ebf4822ff9fa08574edec5dbf4f2a1488f34b1d | |
| ToppCell | Tracheal-NucSeq-Epithelial|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 1.25e-06 | 200 | 174 | 8 | d3af0a706baf66e3f32e67b17dcfc31e5b32ce0e | |
| ToppCell | Tracheal-NucSeq-Epithelial-Epi_submucosal-gland-SMG_Serous|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 1.25e-06 | 200 | 174 | 8 | 7c2d499af60654b7b28f172ac2c914ad49fb74b4 | |
| ToppCell | 10x5'-Liver-Lymphocytic_Invariant-Inducer-like-ILC3|Liver / Manually curated celltypes from each tissue | 3.68e-06 | 163 | 174 | 7 | 7f61483eeb1fde21843c6391468e13cb0cc2a89f | |
| ToppCell | COVID-19-kidney-Lymphatic_EC|kidney / Disease (COVID-19 only), tissue and cell type | 4.31e-06 | 167 | 174 | 7 | 97d0fea1f41c1c00e36d9b5c4c1f0dd85087056f | |
| ToppCell | renal_medulla_nuclei-Adult_normal_reference-Endothelial-lymphatic_endothelial_cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 4.85e-06 | 170 | 174 | 7 | 6035c92cd39c5ac54e7ec57d94888ee19f574639 | |
| ToppCell | renal_medulla_nuclei-Adult_normal_reference-Endothelial-lymphatic_endothelial_cell-lymphatic_endothelial_cell_of_renal_medulla|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 4.85e-06 | 170 | 174 | 7 | c8c42eda44b61440c96b202e7f54650046eb95d3 | |
| ToppCell | renal_medulla_nuclei-Adult_normal_reference-Endothelial-lymphatic_endothelial_cell-lymphatic_endothelial_cell_of_renal_medulla-lymphatic_endothelial_cell_of_renal_medulla|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 4.85e-06 | 170 | 174 | 7 | dcc64b73134e89ae37990d4878813b86ce91dae9 | |
| ToppCell | Control-Epithelial_cells-ECM-high_epithelial|Control / group, cell type (main and fine annotations) | 4.85e-06 | 170 | 174 | 7 | e2023d66e70983c87dacbd6181d3426488d1fc57 | |
| ToppCell | renal_medulla_nuclei-Adult_normal_reference-Mesenchymal-Fibroblast-kidney_interstitial_fibroblast|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 5.04e-06 | 171 | 174 | 7 | 5d31fc9b60329d4ae3c77e4ca679359d9314397d | |
| ToppCell | Control-Epithelial_cells-AT1|Control / group, cell type (main and fine annotations) | 5.65e-06 | 174 | 174 | 7 | 548d7f2b958a2bfd2c95eb049ceaab55a559c77d | |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Mesenchymal-Myocytic_interstitial_cell-Myofibroblast-|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 6.09e-06 | 176 | 174 | 7 | 9bc87cd5cda2372e1bce94c9dfd408eb1dfd8d0c | |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Mesenchymal-Myocytic_interstitial_cell-Myofibroblast|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 6.09e-06 | 176 | 174 | 7 | 3f8274a7ab67f9f8a8923193763a5543cfe4defa | |
| ToppCell | LPS-IL1RA+antiTNF|World / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 6.32e-06 | 177 | 174 | 7 | b7fee75de7e96924af488a5baa2334711889ae7c | |
| ToppCell | Children_(3_yrs)-Epithelial-alveolar_epithelial_cell_type_1/2_(AT1/AT2-like)|Children_(3_yrs) / Lineage, Cell type, age group and donor | 6.80e-06 | 179 | 174 | 7 | cb38b54261a7af5ee3347e64c8aa880a77ed0763 | |
| ToppCell | Control-Endothelial_cells-Capillary_endothelial_cells|Control / group, cell type (main and fine annotations) | 7.06e-06 | 180 | 174 | 7 | b043f9ffb9a4cd427a15bebb86a711c7b08866e8 | |
| ToppCell | RA-16._Neuronal|RA / Chamber and Cluster_Paper | 7.06e-06 | 180 | 174 | 7 | 5842febfdabac61ce970254fb0ef17a628f1b8c0 | |
| ToppCell | 10x3'2.3-week_12-13-Mesenchymal_myocytic|week_12-13 / cell types per 3 fetal stages;per 3',per 5' | 7.32e-06 | 181 | 174 | 7 | 47dce04db3392333eb2f7b9b24c32e6740d2d02f | |
| ToppCell | 10x3'2.3-week_12-13-Mesenchymal_myocytic-stroma|week_12-13 / cell types per 3 fetal stages;per 3',per 5' | 7.32e-06 | 181 | 174 | 7 | 19103221c3a5a16b16378348004b2c50caee4f01 | |
| ToppCell | 5'-Parenchyma_lung-Mesenchymal-Mesenchymal_Myocytic-myocytic_fibroblast-Myofibroblasts-Myofibroblasts_L.2.3.2.2|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 7.32e-06 | 181 | 174 | 7 | b116c68393d8836bac080f81a8fcbeb52e0403e7 | |
| ToppCell | 5'-Adult-LargeIntestine-Mesenchymal-fibroblastic-Stromal_3_(C7+)|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 7.58e-06 | 182 | 174 | 7 | 3dfa9187e9d2bab1d199079d29209c4648220ada | |
| ToppCell | COVID-19-lung-AT1|COVID-19 / Disease (COVID-19 only), tissue and cell type | 7.86e-06 | 183 | 174 | 7 | 7b1a385ed54f93bfe85bf0c162e42d05d516b45c | |
| ToppCell | droplet-Lung-30m-Endothelial-arterial_endothelial-pulmonary_artery_endothelial_cell-pulmonary_artery_endothelial_cell_l27|30m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 7.86e-06 | 183 | 174 | 7 | 351d575339038bd4a66f408da518c567444208e8 | |
| ToppCell | 343B-Epithelial_cells-Epithelial-I_(AT1)-|Epithelial_cells / Donor, Lineage, Cell class and subclass (all cells) | 8.14e-06 | 184 | 174 | 7 | c7073d1b2c4fdb154d87678b92a0629c02116972 | |
| ToppCell | 343B-Epithelial_cells-Epithelial-I_(AT1)|Epithelial_cells / Donor, Lineage, Cell class and subclass (all cells) | 8.14e-06 | 184 | 174 | 7 | 1ed558a88215b248431c524ea16f13d9022ae98c | |
| ToppCell | Adult-Epithelial-alveolar_epithelial_cell_type_1-D122|Adult / Lineage, Cell type, age group and donor | 8.14e-06 | 184 | 174 | 7 | 561592edc3083fad41b91811151b442207c65dd9 | |
| ToppCell | Adult-Epithelial-alveolar_epithelial_cell_type_1-D175|Adult / Lineage, Cell type, age group and donor | 8.44e-06 | 185 | 174 | 7 | 32b4e68e551d435a732f253f6ad83408c759a642 | |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell-Adaptive_/_Maladaptive_/_Repairing_Proximal_Tubule_Epithelial_Cell|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 8.74e-06 | 186 | 174 | 7 | b87acc80b7baa41681e4ed11d5537b9fbf5832f5 | |
| ToppCell | PCW_13-14-Mesenchymal-Mesenchymal_fibroblastic-mes_immature_COL13A1^pos_fibro2_(5)|PCW_13-14 / Celltypes from embryonic and fetal-stage human lung | 9.05e-06 | 187 | 174 | 7 | 13731298bc562ec29582f5da1b4c97261284f6f1 | |
| ToppCell | COVID-19-kidney-Stressed_PCT|kidney / Disease (COVID-19 only), tissue and cell type | 9.05e-06 | 187 | 174 | 7 | acd305475f3609800af0d7bc68d83ef41228080b | |
| ToppCell | COVID-19-Epithelial_cells|COVID-19 / group, cell type (main and fine annotations) | 9.37e-06 | 188 | 174 | 7 | c9cdee6f8d42ee69f5fb335f25084603c511bd29 | |
| ToppCell | facs-Pancreas-Endocrine-24m-Epithelial-pancreatic_B_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 9.37e-06 | 188 | 174 | 7 | a91443aa8fa8fa87f7501c59219daa0305bd0bbf | |
| ToppCell | Control-Epithelial_cells|Control / group, cell type (main and fine annotations) | 9.37e-06 | 188 | 174 | 7 | 707ebf76cc6fb600b2f07793cf4ea9482c0de79d | |
| ToppCell | 3'-Adult-Distal_Rectal-Epithelial-goblet-Goblet_cell|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 9.70e-06 | 189 | 174 | 7 | 7dad62bd50c197838058e89abd0ee387de3e83cd | |
| ToppCell | renal_papilla_nuclei-Adult_normal_reference-Mesenchymal-Fibroblast|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 9.70e-06 | 189 | 174 | 7 | c734e5693808a0333139e87bd5be2597a9252afe | |
| ToppCell | Adult-Epithelial-alveolar_epithelial_cell_type_1-D231|Adult / Lineage, Cell type, age group and donor | 9.70e-06 | 189 | 174 | 7 | 5a04cb25f8f0447b2cecdb6c3695029281aca26d | |
| Drug | p11-13 | 1.13e-07 | 75 | 175 | 8 | CID000015759 | |
| Drug | bipy | 8.38e-07 | 97 | 175 | 8 | CID000001474 | |
| Drug | hydantoin-5-propionic acid | 1.82e-05 | 21 | 175 | 4 | CID000000782 | |
| Drug | 2-chlorodideoxyadenosine | 1.92e-05 | 43 | 175 | 5 | CID000072194 | |
| Drug | chondroitin sulfate | PAPPA2 GCFC2 COMP LAMA5 SPOCK2 ADGRE2 FBLN1 THBS3 THBS4 DST ADAMTS7 NCAN TNR | 1.97e-05 | 413 | 175 | 13 | CID000024766 |
| Drug | Etofylline [519-37-9]; Down 200; 17.8uM; PC3; HT_HG-U133A | 2.26e-05 | 197 | 175 | 9 | 2093_DN | |
| Drug | 3-alpha-Hydroxy-5-beta-androstan-17-one [53-42-9]; Down 200; 13.8uM; MCF7; HT_HG-U133A | 2.26e-05 | 197 | 175 | 9 | 3639_DN | |
| Drug | AZFd | 2.66e-05 | 23 | 175 | 4 | CID000196489 | |
| Disease | cerebral palsy (implicated_via_orthology) | 1.43e-09 | 10 | 169 | 5 | DOID:1969 (implicated_via_orthology) | |
| Disease | body weight | PAPPA2 EHBP1 PCSK5 RELN C6orf89 DSPP RIPK2 PARD3B CRTAC1 DNAH14 SLIT2 BPTF NRXN1 FEZ2 ASXL3 KIAA1217 SLIT1 ELAVL2 KAZN ARHGEF26 PLXNA1 CALN1 PCM1 | 9.51e-07 | 1261 | 169 | 23 | EFO_0004338 |
| Disease | age at onset, multiple sclerosis | 2.15e-05 | 10 | 169 | 3 | EFO_0004847, MONDO_0005301 | |
| Disease | attempted suicide | 7.83e-05 | 178 | 169 | 7 | EFO_0004321 | |
| Disease | intraocular pressure measurement | PCSK5 RELN KALRN C6orf89 PARD3B STOX2 THBS4 NPHP3 FBN1 FEZ2 LRP4 | 1.81e-04 | 509 | 169 | 11 | EFO_0004695 |
| Disease | stroke, coronary artery disease | 2.28e-04 | 21 | 169 | 3 | EFO_0000712, EFO_0001645 | |
| Disease | spontaneous preterm birth | 2.95e-04 | 101 | 169 | 5 | EFO_0006917 | |
| Disease | schizophrenia, sex interaction measurement | 3.94e-04 | 60 | 169 | 4 | EFO_0008343, MONDO_0005090 | |
| Disease | chronotype measurement | RELN GCFC2 TCF20 NAA11 FNBP4 CRTAC1 RFTN2 RGL1 NRXN1 HECW2 NAV3 PDZD8 KAZN CALN1 | 5.84e-04 | 882 | 169 | 14 | EFO_0008328 |
| Disease | wellbeing measurement | EHBP1 FAT4 ZSCAN12 NAA11 FNBP4 SPOCK2 ODAD2 UBOX5 BPTF ASXL3 LRP4 ELAVL2 | 6.75e-04 | 692 | 169 | 12 | EFO_0007869 |
| Disease | bipolar II disorder | 8.93e-04 | 8 | 169 | 2 | EFO_0009964 | |
| Disease | cleft palate (implicated_via_orthology) | 8.93e-04 | 8 | 169 | 2 | DOID:674 (implicated_via_orthology) | |
| Disease | diet measurement | RNF168 TCF20 KCTD8 ALPK1 RALGAPA2 MINDY2 UBOX5 APLF DNAH14 DST HECW2 KIAA1217 NGEF EEA1 CNGB1 | 1.08e-03 | 1049 | 169 | 15 | EFO_0008111 |
| Disease | visceral heterotaxy (implicated_via_orthology) | 1.24e-03 | 37 | 169 | 3 | DOID:0050545 (implicated_via_orthology) | |
| Disease | cystic kidney disease (implicated_via_orthology) | 1.42e-03 | 10 | 169 | 2 | DOID:2975 (implicated_via_orthology) | |
| Disease | cognitive function measurement | EFL1 AFTPH TCF20 KALRN DSPP MAGEB18 PARD3B EDEM3 RGL1 STOX2 NRXN1 KIAA1217 ZNF335 ELAVL2 EEA1 MUC2 TNR CALN1 | 1.52e-03 | 1434 | 169 | 18 | EFO_0008354 |
| Disease | brain infarction (implicated_via_orthology) | 1.73e-03 | 11 | 169 | 2 | DOID:3454 (implicated_via_orthology) | |
| Disease | mean corpuscular hemoglobin concentration | RMND5A KALRN C6orf89 RNF43 THBS3 NPHP3 HECW2 KIAA1217 NCAN PLCB3 ATF4 AGAP7P ZNF654 EPB41 GOLGB1 | 1.79e-03 | 1105 | 169 | 15 | EFO_0004528 |
| Disease | osteoarthritis | 1.81e-03 | 222 | 169 | 6 | MONDO_0005178 | |
| Disease | triglyceride measurement, very low density lipoprotein cholesterol measurement | 1.90e-03 | 224 | 169 | 6 | EFO_0004530, EFO_0008317 | |
| Disease | amino acid measurement | FAT4 GCFC2 VGLL2 ODAD2 SLIT2 RGL1 SLIT1 NAV3 ELAVL2 COBL MUC2 | 1.91e-03 | 678 | 169 | 11 | EFO_0005134 |
| Disease | cortical surface area measurement | TRPM6 RELN PDE3A TUT7 PARD3B CRTAC1 SLC12A8 NCKAP5 FAM117B RFTN2 STOX1 SLIT2 FBN1 ADAMTS7 NAV3 ELAVL2 SPAG17 | 1.91e-03 | 1345 | 169 | 17 | EFO_0010736 |
| Disease | hypertrophic cardiomyopathy | 1.96e-03 | 92 | 169 | 4 | EFO_0000538 | |
| Disease | stomach carcinoma (is_implicated_in) | 2.07e-03 | 12 | 169 | 2 | DOID:5517 (is_implicated_in) | |
| Disease | FVC change measurement, response to placebo | 2.44e-03 | 13 | 169 | 2 | EFO_0008344, EFO_0010339 | |
| Disease | dyslexia | 2.46e-03 | 162 | 169 | 5 | EFO_0005424 | |
| Disease | Kartagener syndrome (implicated_via_orthology) | 2.84e-03 | 14 | 169 | 2 | DOID:0050144 (implicated_via_orthology) | |
| Disease | beta-amyloid 1-42 measurement, cerebrospinal fluid biomarker measurement | 2.84e-03 | 14 | 169 | 2 | EFO_0004670, EFO_0006794 | |
| Disease | leprosy | 2.96e-03 | 103 | 169 | 4 | EFO_0001054 | |
| Disease | cognitive inhibition measurement | 2.97e-03 | 50 | 169 | 3 | EFO_0007969 | |
| Disease | corneal topography | 3.62e-03 | 109 | 169 | 4 | EFO_0004345 | |
| Disease | Small cell carcinoma of lung | 3.70e-03 | 54 | 169 | 3 | C0149925 | |
| Disease | systemic lupus erythematosus, COVID-19 | 4.52e-03 | 58 | 169 | 3 | MONDO_0007915, MONDO_0100096 | |
| Disease | borna disease (biomarker_via_orthology) | 4.70e-03 | 18 | 169 | 2 | DOID:5154 (biomarker_via_orthology) | |
| Disease | idiopathic dilated cardiomyopathy | 4.97e-03 | 60 | 169 | 3 | EFO_0009094 | |
| Disease | primary ciliary dyskinesia (implicated_via_orthology) | 5.23e-03 | 19 | 169 | 2 | DOID:9562 (implicated_via_orthology) | |
| Disease | hippocampal tail volume | 5.23e-03 | 19 | 169 | 2 | EFO_0009398 | |
| Disease | unipolar depression, response to bupropion, mood disorder | 5.23e-03 | 19 | 169 | 2 | EFO_0003761, EFO_0004247, EFO_0006326 | |
| Disease | diastolic blood pressure, systolic blood pressure | 5.43e-03 | 670 | 169 | 10 | EFO_0006335, EFO_0006336 | |
| Disease | atrial fibrillation | 5.70e-03 | 371 | 169 | 7 | EFO_0000275 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| QEEEDNSCGTLNSTL | 1616 | Q8WWZ7 | |
| DNERSIPNDGTCFQE | 321 | Q9H6S1 | |
| PGSQQVSDFEDNTCE | 976 | Q9H2P0 | |
| EFDQQQGSVCPSESE | 16 | Q96P64 | |
| QEPQQEESCQTAAEG | 31 | P11171 | |
| SLEFDQQQGSVCPSE | 156 | Q5VTM2 | |
| ENCSSAQGDSLQDES | 326 | Q8IW19 | |
| SPNGPNNTVCEDVDE | 201 | Q9UHX3 | |
| CSSENPQLSPNLEDD | 106 | Q86TB3 | |
| SVPNIQDDCNGFQDS | 541 | Q6ULP2 | |
| QCIKEEDTPSDNDSG | 206 | P18848 | |
| NSNPVEDEDAVALTC | 331 | P06731 | |
| DNCPTVPNSAQEDSD | 446 | P49747 | |
| DDEQSAFACNTRQPG | 46 | Q969M2 | |
| EENETCSGGNENQEL | 916 | Q7Z2Z2 | |
| FQNSSEREDCNNGEP | 51 | Q9Y297 | |
| ASLTVDSCSENQEPG | 4071 | Q6V0I7 | |
| ENSCRNEGNTSEITP | 201 | Q9NZW4 | |
| SCDNEELNSSPGKNS | 716 | Q96DR7 | |
| NLTNNIPGCEEEDAS | 286 | Q8IYA2 | |
| ESPCVGNLNDSEGLN | 1141 | Q8IYA2 | |
| NDQPEDLIQGCSESD | 1256 | Q12830 | |
| NEEESLNETSGNCQT | 201 | Q9BXU9 | |
| SDPEEQLSENACISE | 596 | Q9C0F0 | |
| NDTGVPCDEAQQPAS | 971 | Q9UKP4 | |
| CVNTQTGLPEEDSDQ | 1596 | Q9UKP4 | |
| LSEDCTTTEEGNQPG | 901 | Q96QP1 | |
| EFDQQQGSVCPSESE | 16 | Q5VW22 | |
| VSCGQAESSEKPNAE | 31 | Q99873 | |
| EQAVSPKVDDQCGNS | 331 | Q5T7V8 | |
| ATNDGNHPSCQETRD | 216 | P0DJD3 | |
| ATNDGNHPSCQETRD | 216 | A6NDE4 | |
| ATNDGNHPSCQETRD | 216 | P0DJD4 | |
| ATNDGNHPSCQETRD | 216 | P0C7P1 | |
| ATNDGNHPSCQETRD | 216 | A6NEQ0 | |
| ATNDGNHPSCQETRD | 216 | Q15415 | |
| EECPLTSEAQTNDAA | 126 | Q52LD8 | |
| TSPNCEEDGSQSSSE | 121 | Q9NZL6 | |
| EHGEQACERDQSQPS | 211 | Q4KMZ1 | |
| DQGSAELCGSQEVDQ | 561 | Q9P2P5 | |
| QSDGTQESCESPDVL | 351 | Q9UGV2 | |
| ALNCESAPQGNSELE | 811 | Q8TEW8 | |
| CQSDLEDNVSQGSSD | 161 | Q6ZWB6 | |
| NSDEESCESSQEPGS | 141 | Q86YD5 | |
| QNEDCGDDDPQSRLE | 746 | Q674X7 | |
| PVSCSSNEGASSQDE | 76 | Q96M61 | |
| QGAESDQAEPIICSS | 271 | Q7Z434 | |
| ECTEDELNNLGHPDN | 316 | Q9UDY8 | |
| ANSCQSDSSGFLEEP | 416 | Q6ZRS4 | |
| LESSDLVDQTEGCQP | 1071 | Q9NRM7 | |
| GESNLTNGDEPTQCS | 536 | Q96T76 | |
| NDTHTPESNGNKCEA | 2241 | Q03001 | |
| RSEEDSGSQSCEQAP | 896 | Q76N89 | |
| GPQDSAQFECVVSNE | 3821 | Q8NDA2 | |
| PSDDENSDNSNECVV | 266 | O60291 | |
| NPTENHETTNLNGEC | 866 | Q9BZQ6 | |
| SQDYDQLPSCSDGSQ | 886 | Q13191 | |
| LESCSDDDNQGSKSP | 126 | Q5T3I0 | |
| EEQDASSNDNFSVCP | 921 | Q15154 | |
| PADTSCQVDTSCQGD | 326 | A6NKB5 | |
| DALASCDVNGNDLDP | 186 | Q92824 | |
| INSPLQIDDDFCGQD | 396 | Q9UIW2 | |
| NSCQDSEADEETSPG | 311 | Q86W56 | |
| PSGEIVSNCEAAADQ | 4636 | Q02817 | |
| TPNTSDNEGSDTEVC | 971 | Q8NEN9 | |
| APAPNEEETCENNES | 1046 | Q14432 | |
| LAEQCSADNNGVELP | 2106 | Q8IVL0 | |
| ALSLGQDPSNDCNDN | 81 | Q86SU0 | |
| TNSSEESECDDLDPN | 2441 | O60229 | |
| GEQDNCEIETSNGLS | 56 | Q8IV20 | |
| QELTDPTCDTDSGQC | 1536 | O15230 | |
| EGPSTTCQEDSCSNQ | 1081 | Q9ULB1 | |
| VEECQQSENAPAAGS | 736 | Q2PPJ7 | |
| DALAQQLCEQGAPTD | 171 | P78509 | |
| DGLSCQDINECQESS | 5186 | Q96RW7 | |
| GQVCANDSDTLELPD | 51 | Q96RI0 | |
| GESEAQAGQETCQDT | 881 | Q01970 | |
| NEQDRCATPHGDNAS | 86 | P23142 | |
| PGDSQNNADATDCQI | 31 | Q17RF5 | |
| SAPSNCISEDEGQNH | 1366 | Q9BXP8 | |
| DVNNESSSEGFICPQ | 31 | Q15075 | |
| STPQRFECDQEEGAN | 286 | P26951 | |
| CSEGSEQQDAPDDSQ | 1116 | Q9Y2F5 | |
| NCNHQEGTSSDDELP | 421 | P16383 | |
| GFTASPNQDECLDNR | 2321 | P35555 | |
| LNAEVQGQQPECDST | 841 | Q8IW35 | |
| ISNEGSEESPCSADD | 421 | Q6P1L5 | |
| SEDGGLQESNPCADD | 246 | Q8NBF6 | |
| GSDNCSLADEEQTPR | 631 | Q5TH69 | |
| QEDCSDQDLAGTPDL | 436 | O75128 | |
| SSGHDLIQCNQDQPD | 401 | Q9NQT6 | |
| GECSSPDIQNSVEEE | 556 | Q5VWK5 | |
| NLTNNIPGCEEEDAS | 336 | Q3MJ40 | |
| EFDQQQGSVCPSESE | 16 | Q5VUJ5 | |
| ETCSLLDQGQEPDQS | 681 | Q5SZL2 | |
| DNSFPTGKTTNDCEE | 476 | Q0VDD8 | |
| SDDPGICSNTDSTQA | 666 | Q8NDI1 | |
| INNNCSSPVDSGNTE | 21 | Q12926 | |
| DGNCEPAKNSESVDQ | 21 | Q9NRY5 | |
| NNSPDGNTDSSALDC | 381 | Q14145 | |
| SSASDIFCDNENGPN | 251 | Q9NQ79 | |
| GDEQSDFECNTAQPG | 46 | P35212 | |
| NLTNNIPGCEEEDAS | 336 | A2RUR9 | |
| ESPCVGNLNDSEGLN | 1331 | A2RUR9 | |
| TNDCEQNESEPIPAN | 141 | Q6UWU4 | |
| CGDPEENCAATTTQS | 46 | P35070 | |
| VPELCNQSESSGEDF | 556 | A0AV02 | |
| SENSCLEDSDPSNLG | 386 | Q8TDX9 | |
| CLPSASDENENQLDG | 31 | Q6PJW8 | |
| LDQENCNASPEPGAE | 21 | Q9UHY8 | |
| ADVGPSADEVNNNTC | 951 | Q12756 | |
| SGTDQLSCNSEQKPD | 181 | Q12923 | |
| GDASECPQATNAKDS | 731 | O14830 | |
| ATGEPNFANEDENCV | 886 | P22897 | |
| PSSCEFNSEEGAENR | 186 | Q8NBR6 | |
| TNAGNEPDLEDEQVC | 1271 | Q93008 | |
| ESDCDPGDQPESQQA | 231 | O94941 | |
| EELCQESGLSVDPSQ | 136 | Q9H871 | |
| SGDSSAIPQANCDSE | 311 | O75159 | |
| EKQCVGEDQPSDSDS | 6 | Q8N4U5 | |
| DPSQEDLCSVVQSGE | 381 | Q8N3X1 | |
| EDQQAFTQGECPSAN | 1386 | O14513 | |
| QVFDPGESDSDDNCT | 206 | Q7Z494 | |
| DANQTIQDSKPDSCE | 601 | Q9HCM1 | |
| PDQDLQEAAAGCISN | 1016 | Q5T2S8 | |
| NAGAEEVHSDPCENN | 1001 | O14594 | |
| PERNASCLADSQDNG | 81 | Q8N5V2 | |
| CNASDDDNLEPGFIS | 91 | Q68DV7 | |
| SPNSECKGEDATDDQ | 1551 | Q5T5P2 | |
| AEEGQSTPRQADAQC | 956 | Q13796 | |
| ESNREPSDPSQCDAN | 686 | Q6Q759 | |
| EFDQQQGSVCPSESE | 16 | A6NIR3 | |
| NSGEPNNSGNEDCAE | 356 | Q9H2X3 | |
| NDTSNFCPGLQAADS | 556 | Q15003 | |
| GQRFDPETNSDDACT | 11 | Q9UHD1 | |
| DTGCTDEPNEALEAQ | 136 | Q14028 | |
| PNQSDVDNDLVGDSC | 611 | P35443 | |
| VDNDLVGDSCDTNQD | 616 | P35443 | |
| NAETCNATGPDLEFS | 691 | O94967 | |
| NGAAACPLATEQQSD | 171 | A0A0J9YY54 | |
| DGSPNDCESIEDLLN | 926 | Q5W0Q7 | |
| QCSGSVQDPINEDQS | 1701 | Q8N2C7 | |
| NTAENQPGEHSLECN | 111 | Q13360 | |
| ACSQSDQLNPEPGEN | 1601 | Q9BX84 | |
| QEAQECNASPSSSGS | 36 | Q8N8G2 | |
| ESCSQEEASERGPQE | 221 | P12524 | |
| ACQQKNPATEESGSD | 191 | Q9BSU3 | |
| ESQEPNLSAESCGLN | 811 | Q6ZVD7 | |
| DLAEGCSQDDQTPSQ | 511 | Q9P2F5 | |
| PQEESCGSSQLHENS | 341 | O43353 | |
| DNLCSSGLEASAEQE | 76 | Q92752 | |
| ESEKDNSQCCDPATN | 26 | Q6AZW8 | |
| GNLESDGDCLQAESE | 721 | O15015 | |
| PDIEPNSENNCSSSD | 961 | Q8IZM8 | |
| EGENTQVAEPEACDQ | 41 | Q9BRT2 | |
| ESTEESSNCENGSPQ | 36 | O43680 | |
| TCDDGNDDNSCSPLS | 711 | O94813 | |
| DSCTNSEGSSQPEEQ | 496 | Q9UGU0 | |
| DNCLLTPNSGQEDAD | 481 | P49746 | |
| GNNTGETENEESCLL | 366 | Q8IYW5 | |
| CEPSENNLGSENSAF | 11 | Q8NAM6 | |
| SSPVQEDAENASCEL | 411 | Q9Y2K1 | |
| VCTQDDLPSTDESGN | 696 | A7E2V4 | |
| KQPGENSDCHRDSSQ | 226 | P17098 | |
| NSEPCAGSSSESDLQ | 256 | Q8N806 | |
| NQESYEDGPCTITSN | 256 | Q9Y2L5 | |
| EDGPCTITSNKNSDN | 261 | Q9Y2L5 | |
| NCSSSPTIEIQENGD | 151 | Q9H0M0 | |
| PENSDCIQADVNSDD | 721 | Q5VYS8 | |
| EDCQASGNTLDSALE | 316 | Q9Y462 | |
| PGTEDYQLNSECNSD | 496 | O75093 | |
| TDPPDGQQDSECNRN | 116 | Q9NUQ3 | |
| SQSDAENAAPSCPDE | 416 | Q9H4Z2 | |
| PTCDENGVSLTENSD | 246 | O43309 | |
| ESNGLNEDILDNPCN | 251 | Q9BVW5 | |
| ETQGQEDNKTGPCSN | 91 | A6NL46 | |
| NQQGDEALDTTKDPC | 76 | Q92563 | |
| QGQCGEEEDSLDLSS | 221 | Q49AM3 | |
| TDQQESCSSTPGLEE | 1251 | Q14789 | |
| ADNSDEENCENTGSP | 296 | O75096 | |
| QAERDGDSCSISPQD | 341 | Q9ULV0 | |
| GSNQNYICNTDPETD | 476 | O75113 | |
| ENNQEDCDLANSGPL | 731 | Q86UW6 | |
| QSTCDAERGNSEQAE | 1191 | Q86UW6 | |
| ASSCGKEVPEDSNNF | 376 | Q9ULJ8 |